A direct effect of SCFAs on renin release and vasomotor function leading to blood pressure reduction was recently suggested in experimental hypertension, and propionate treatment shows a blood pressure-lowering effect in the hypertensive mice (Bartolomaeus et al., 2019). This evidence concerns the gene REN and hypertensive disorder.